Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Litigation Details for Lupin Limited v. Abbott Laboratories (E.D. Va. )

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Small Molecule Drugs cited in Lupin Limited v. Abbott Laboratories
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Lupin Limited v. Abbott Laboratories (E.D. Va. )

Date Filed Document No. Description Snippet Link To Document
2007-04-27 188 construction of U.S. Patent No. 4,935,507 (“´507 patent”). The ´507 patent relates to the antibiotic… is the preferred form of cefdinir. U.S. Patent No. 4,935,507 col.1 ll.27-28 (filed Aug. 8, 1988). … the solution to stand. U.S. Patent No. 4,935,507 col.16 ll.12-50 (filed Aug. 8, 1988). …United States, two patents for cefdinir. According to Astellas, the first, U.S. Patent No. 4,559,334 (“…2007. The ´507 patent, the patent-in-suit, does not expire until December 4, 2011 and covers External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.